A. Nattermann & Cie Gmbh

Nattermann & Cie Gmbh

Hugo Friehe

Hans-Heiner Lautenschlager

Gerd Hilboll

Josef P Lohr

Eugen Etschenberg

Jurgen Biedermann

Johannes Winkelmann

Wolfgang Scheef

The invention relates to new 6-{4-(.omega.-(1-imidazolyl)-alkyl)-phenyl}-3-oxo-2,3,4,5-tetrahydro-pyrid azines having the general formula I ##STR1## and acid addition salts thereof, and to a process for the treatment of inflammatory, atherosclerotic and thromboembolic diseases especially in humans.

6-{4-(.omega.-(1-imidazolyl)-alkyl-phenyl}-3-oxo-2,3,4,5-tetrahydro-

The invention relates to the new optically active dipeptide D-2-phenylglycyl-D-2-phenylglycine and its pharmacologically acceptable salts or acid addition salts and the use thereof as tissue dissolving and histolytic agent.

Optically active dipeptides and the use thereof as tissue dissolving and

The invention relates to new 6-{5-[.omega.-(1-imidazolyl)-alkyl]-thien-2-yl}-3-oxo-2,3,4,5-tetrahydro-p yridazines having the general formula I ##STR1## and acid addition salts thereof and to a process for the treatment of inflammatory, atherosclerotic and thrombo-embolic diseases especially in humans.

6-{5-[.omega.-(1-Imidazolyl)-alkyl]

Growing community of inventors

Erftstadt-Lechenich, Germany

Hugo Friehe